Matthew S. Abbott

Insider Reports History

Entity
Individual
Location
C/O The Chemours Company, 1007 Market Street, Wilmington, Delaware
Signature
/s/ Nicole Perez Lengel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew S. Abbott:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Chemours Co Interim CFO Common Stock 46,106 $1.33 M $28.88 May 8, 2024 Direct
Chemours Co Interim CFO Stock Option (Right to Buy) 31,614 $456 K $14.43 May 8, 2024 Direct
Chemours Co Interim CFO Performance Stock Option (Right to Buy) 32,879 May 8, 2024 Direct

Insider Reports Filed by Matthew S. Abbott

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CC Chemours Co May 8, 2024 3 0 4 May 10, 2024 Interim CFO
CC Chemours Co Mar 27, 2024 2 -58,886 4 Mar 29, 2024 Interim CFO
CC Chemours Co Mar 1, 2024 1 -91,744 4 Mar 5, 2024 Interim CFO
CC Chemours Co Aug 1, 2023 1 0 4 Aug 3, 2023 SVP, Chief Enterprise Transfor
CC Chemours Co Jun 8, 2023 3 -176,190 4 Jun 9, 2023 SVP, Chief Enterprise Transfor
CC Chemours Co Jun 6, 2023 0 0 3 Jun 7, 2023 SVP, Chief Enterprise Transfor
CC Chemours Co May 27, 2021 3 -188,777 4 May 27, 2021 VP, CAO & Controller